CoChat

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase‐4 inhibitors and sulphonylureas: a primary care database analysis

Rathmann, W., Kostev, K., Gruenberger, J. B., Dworak, M., Bader, G., Giani, G. · 2013 · Diabetes, Obesity and Metabolism
Cited by 93

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aims: To investigate therapy persistence, frequency of hypoglycaemia and macrovascular outcomes among type 2 diabetes patients with dipeptidyl peptidase‐4 ( DPP ‐4) inhibitors ( DPP ‐4) and sulphonylureas ( SU ). Methods: Data from 19 184 DPP ‐4 (mean age: 64 years; 56% males) and 31 110 SU users (69 years; 51%) with new prescriptions (index date), without additional antidiabetics except metformin, in 1201 general practises in Germany were analysed. Therapy discontinuation (prescription gap >90 days), hypoglycaemia [International Classification of Diseases (ICD‐10)] and macrovascular outcomes ( ICD ‐10) (2‐year follow‐up) were compared adjusting for age, sex, diabetes duration, metformin, previous hypoglycaemia, health insurance, hypertension, hyperlipidaemia, antihypertensives, lipid‐lowering and antithrombotic drugs, microvascular complications and Charlson co‐morbidity score using logistic or Cox regression models. Results: Two years after index date, DDP ‐4 (non‐persistence: 39%) were associated with a lower risk of discontinuation compared to SU (49%) [adjusted hazard ratio ( HR ): 0.74; 95% confidence interval (CI): 0.71–0.76]. Hypoglycaemias (≥1) were documented in 0.18% patients with DPP ‐4 and in 1.00% with SU [odds ratio (OR): 0.21; 95% CI : 0.08–0.57]. Hypoglycaemias were significantly associated with incident macrovascular complications ( HR : 1.6; 95% CI: 1.1–2.2). Risk of macrovascular events was 26% lower in DPP ‐4 than in SU users. Conclusions: Lack of persistence with antidiabetic therapy is frequently found in primary care patients. DPP ‐4 was associated with lower therapy discontinuation and a fivefold reduced frequency of patients with hypoglycaemia compared to SU . The low absolute numbers of hypoglycaemias are most likely due to the fact that only severe events were documented. DPP ‐4 treatment was associated with reduced incidence of macrovascular events relative to SU in type 2 diabetes patients in primary care practises.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2012.01674.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 93

Metadata

Authors
Rathmann, W., Kostev, K., Gruenberger, J. B., Dworak, M., Bader, G., & Giani, G.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2012-09-09
Volume
15
Issue
1
Pages
55-61
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2163153907
Cited by
93
References
7
FWCI
8.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase‐4 inhibitors and sulphonylureas: a primary care database analysis. https://app.cochat.ai/papers/10.1111/j.1463-1326.2012.01674.x
The paper
Rathmann, W., Kostev, K., Gruenberger, J. B., Dworak, M., Bader, G., & Giani, G. (2013). Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase‐4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2012.01674.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.